Corrêa FA, de Arruda JAA, Drumond VZ, Cepeda IVB, Tarquinio SBC, Silva TA, Abreu LG, Rivero ERC, Mesquita RA, Etges A. Pharmacological therapy for central giant cell granuloma of the jaws: A systematic review. J Clin Exp Dent. 2024;16(7):e885-97.

 

doi:10.4317/jced.61490

https://doi.org/10.4317/jced.61490

_____

 

References

1. Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A. Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg. 1986;44:708-13.
https://doi.org/10.1016/0278-2391(86)90040-6
PMid:3462363

 

2. Nosé V, Lazar AJ. Update from the 5th edition of the World Health Organization classification of head and neck tumors: familial tumor syndromes. Head Neck Pathol. 2022;16:143-57.
https://doi.org/10.1007/s12105-022-01414-z
PMid:35312981 PMCid:PMC9018953

 

3. Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-oseous) dysplasia of the jawbones. Oral Surg Oral Med Oral Pathol. 1953;6:159-75.
https://doi.org/10.1016/0030-4220(53)90151-0
PMid:13026160

 

4. Alsufyani NA, Aldosary RM, Alrasheed RS, Alsaif RF. A systematic review of the clinical and radiographic features of hybrid central giant cell granuloma lesions of the jaws. Acta Odontol Scand. 2021;79:124-31.
https://doi.org/10.1080/00016357.2020.1797160
PMid:32730731

 

5. Schreuder WH, van den Berg H, Westermann AM, Peacock ZS, de Lange J. Pharmacological and surgical therapy for the central giant cell granuloma: A long-term retrospective cohort study. J Craniomaxillofac Surg. 2017;45:232-43.
https://doi.org/10.1016/j.jcms.2016.11.011
PMid:28087284

 

6. Miguita L, de Souza JC, Bastos VC, Pereira NB, de Freitas RAB, Guimarães LM, et al. Central giant cell granulomas of the jaws stromal cells harbour mutations and have osteogenic differentiation capacity, in vivo and in vitro. J Oral Pathol Med. 2022;51:206-16.
https://doi.org/10.1111/jop.13274
PMid:35048460

 

7. Chrcanovic BR, Gomes CC, Gomez RS. Central giant cell lesion of the jaws: an updated analysis of 2270 cases reported in the literature. J Oral Pathol Med. 2018;47:731-9.
https://doi.org/10.1111/jop.12730
PMid:29751369

 

8. Abdo EN, Alves LC, Rodrigues AS, Mesquita RA, Gomez RS. Treatment of a central giant cell granuloma with intralesional corticosteroid. Br J Oral Maxillofac Surg. 2005;43:74-6.
https://doi.org/10.1016/j.bjoms.2004.08.015
PMid:15620781

 

9. Chrcanovic BR, Gomes CC, Dos Santos TR, Abreu MHNG, Gomez RS. Clinical factors associated with the recurrence of central giant cell lesions. J Oral Pathol Med. 2019;48:799-802.
https://doi.org/10.1111/jop.12937
PMid:31353534

 

10. Camarini C, de Souza Tolentino E. Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review. Clin Oral Investig. 2022;26:2111-32.
https://doi.org/10.1007/s00784-021-04193-z
PMid:34599398

 

11. de Lange J, van den Akker HP, van den Berg H. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:603-15.
https://doi.org/10.1016/j.tripleo.2007.04.003
PMid:17703964

 

12. Suárez-Roa Mde L, Reveiz L, Ruíz-Godoy Rivera LM, Asbun-Bojalil J, Dávila-Serapio JE, Menjívar-Rubio AH, et al. Interventions for central giant cell granuloma (CGCG) of the jaws. Cochrane Database Syst Rev. 2009;CD007404.
https://doi.org/10.1002/14651858.CD007404.pub2
PMid:19821413

 

13. Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014;7:264.
https://doi.org/10.1186/1756-0500-7-264
PMid:24758689 PMCid:PMC4001358

 

14. Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB. Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg. 2002;60:1103-11; discussion 1111-13.
https://doi.org/10.1053/joms.2002.34975
PMid:12378481

 

15. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; CARE Group*. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013;2:38-43.
https://doi.org/10.7453/gahmj.2013.008
PMid:24416692 PMCid:PMC3833570

 

16. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.
https://doi.org/10.1016/j.ijsu.2021.105906
PMid:33789826

 

17. Adornato MC, Paticoff KA. Intralesional corticosteroid injection for treatment of central giant-cell granuloma. J Am Dent Assoc. 2001;132:186-90.
https://doi.org/10.14219/jada.archive.2001.0153
PMid:11217591

 

18. Al-Ahmad HT, Anabtawi M, Salfiti F, Eid RA. Combination of surgery followed by intralesional steroids in treatment of aggressive mandibular giant cell granuloma: a case report. Jordan Med J. 2009;43:231-7.

 

19. Al-Jandan B. Combined management of large aggressive central giant cell granuloma of the mandible: a case report. Saudi J Dent Res. 2015;6:157-60.
https://doi.org/10.1016/j.sjdr.2014.12.003

 

20. Al-Layla AM, Mahazfa T. Giant cell granuloma of the maxillary sinus; a case report. Jordan Med J. 2013;47:260-5.
https://doi.org/10.12816/0025821

 

21. Aoki T, Karakida K, Sakamoto H, Yamazaki H, Otsuru M, Sasaki M, et al. Successful treatment by intralesional steroid injection in management of central giant cell granuloma of the jaw-report of two cases. J Oral Maxillofac Surg Med Pathol. 2012;24:213-7.
https://doi.org/10.1016/j.ajoms.2011.11.007

 

22. Aurora JK, Chauhan H, Loomba K, Potlia I. Novel regimen of combined intralesional triamcinolone and salmon calcitonin nasal spray to treat a large central giant cell granuloma. Natl J Maxillofac Surg. 2022;13:S131-5.
https://doi.org/10.4103/njms.NJMS_185_20
PMid:36393951 PMCid:PMC9651218

 

23. Baker SB, Parikh PM, Rhodes DN, Abu-Ghosh A, Shad AT. Aggressive central giant cell lesion of the maxilla: surgical management and the use of adjuvant interferon alfa-2a. Plast Reconstr Surg. 2008;122:77-9.
https://doi.org/10.1097/PRS.0b013e31817d5f3d
PMid:18626327

 

24. Bayar OF, Ak G. Treatment of giant cell granuloma with intralesional corticosteroid injections: a case report. J Istanb Univ Fac Dent. 2015;49:45-50.
https://doi.org/10.17096/jiufd.88120
PMid:28955545 PMCid:PMC5573504

 

25. Cavalcante IL, Barros CCS, Osterne RLV, Cavalcante RB, Nogueira RLM, Medeiros RCT. Conservative therapy for central giant cell lesion: case report J Bras Patol Med Lab. 2017;53:403-6.
https://doi.org/10.5935/1676-2444.20170065

 

26. Chien MC, Mascarenhas L, Hammoudeh JA, Venkatramani R. Zoledronic acid for the treatment of children with refractory central giant cell granuloma. J Pediatr Hematol Oncol. 2015;37:e399-401.
https://doi.org/10.1097/MPH.0000000000000380
PMid:26056788 PMCid:PMC7497845

 

27. Choi JW, Kraut RA. Management of central giant granuloma of mandible with intralesional triamcinolone injections: a case report. N Y State Dent J. 2013;79:34-6.

 

28. Comert E, Turanli M, Ulu S. Oral and intralesional steroid therapy in giant cell granuloma. Acta Otolaryngol. 2006;126:664-6.
https://doi.org/10.1080/00016480500468976
PMid:16720455

 

29. da Rosa MRP, de Sá JL, Martins VB, de Oliveira MV. Central giant cells lesion: report of a conservative management. Eur J Dent. 2018;12:305-10.
https://doi.org/10.4103/ejd.ejd_402_17
PMid:29988246 PMCid:PMC6004816

 

30. da Silva NG, Carreira AS, Pedreira EN, Tuji FM, Ortega KL, de Jesus Viana Pinheiro J. Treatment of central giant cell lesions using bisphosphonates with intralesional corticosteroid injections. Head Face Med. 2012;8:23.
https://doi.org/10.1186/1746-160X-8-23
PMid:22913518 PMCid:PMC3489779

 

31. da Silva Sampieri MB, Yaedú RY, Santos PS, Gonçales ES, Santa'ana E, Consolaro A, et al. Central giant cell granuloma: treatment with calcitonin, triamcinolone acetonide, and a cystic finding 3 years and 6 months after the primary treatment. Oral Maxillofac Surg. 2013;17:229-34.
https://doi.org/10.1007/s10006-012-0370-5
PMid:23111768

 

32. de Arruda JAA, Martins AFL, Abreu LG, Mesquita RA, von Zeidler SV, Estrela C, et al. Central giant cell granuloma of the maxilla: long-term follow-up of a patient treated with an adjuvant corticosteroid. Spec Care Dentist. 2021;41:399-407.
https://doi.org/10.1111/scd.12569
PMid:33471401

 

33. de Lange J, van den Akker HP, van den Berg H, Richel DJ, Gortzak RA. Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 cases. Int J Oral Maxillofac Surg. 2006;35:865-9.
https://doi.org/10.1016/j.ijom.2006.02.011
PMid:16584870

 

34. de Mendonça RP, Mitre GP, Real FH, da Silva Kataoka MS, de Melo Alves Júnior S, Vianna P, et al. Central giant cell granuloma treated with intralesional corticosteroid injections and bisphosphonates: a long-term follow-up case study. Head Neck Pathol. 2020;14:497-502.
https://doi.org/10.1007/s12105-019-01053-x
PMid:31297738 PMCid:PMC7235135

 

35. de Oliveira JP, Olivete F, de Oliveira ND, Giovanini AF, Zielak JC, Klüppel L, et al. Combination therapies for the treatment of recurrent central giant cell lesion in the maxilla: a case report. J Med Case Rep. 2017;11:74.
https://doi.org/10.1186/s13256-016-1173-3
PMid:28316283 PMCid:PMC5357802

 

36. de Oliveira LJ, Lehman LFC, Gomez RS, Castro WH. Treatment of central giant cell lesions. Oral Surg. 2016;9:52-7.
https://doi.org/10.1111/ors.12161

 

37. El Hadidi YN, Ghanem AA, Helmy I. Injection of steroids intralesional in central giant cell granuloma cases (giant cell tumor): is it free of systemic complications or not? A case report. Int J Surg Case Rep. 2015;8C:166-70.
https://doi.org/10.1016/j.ijscr.2015.02.001
PMid:25699662 PMCid:PMC4353960

 

38. Fernandes Gonçalves IM, Barbosa Luna AH, de Melo DP, Weege Nonaka CF, Alves PM. Pharmacological therapy for treatment of recurrent central giant cell lesion in a child. J Dent Child (Chic). 2019;86:113-7.

 

39. Ferretti C, Muthray E. Management of central giant cell granuloma of mandible using intralesional corticosteroids: case report and review of literature. J Oral Maxillofac Surg. 2011;69:2824-9.
https://doi.org/10.1016/j.joms.2010.11.020
PMid:21292370

 

40. Fonseca FP, Ribeiro AC, Santos-Silva AR, Vargas PA, Lopes MA. Fine needle aspiration cytology and intralesional steroid injection in a central giant cell granuloma affecting the gingiva: a new clinical approach. Braz Dent J. 2013;24:420-7.
https://doi.org/10.1590/0103-6440201302196
PMid:24173268

 

41. Goldman KE, Marshall MK, Alessandrini E, Bernstein ML. Complications of alpha-interferon therapy for aggressive central giant cell lesion of the maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:285-91.
https://doi.org/10.1016/j.tripleo.2004.11.024
PMid:16122654

 

42. Goyal P, Narula R, Bansal S, Bansal S, Garg P. Conservative nonsurgical treatment of mandibular central giant cell granuloma in an adolescent: a case report. Pediatr Dent J. 2014;24:58-62.
https://doi.org/10.1016/j.pdj.2013.12.002

 

43. Gupta B, Stanton N, Coleman H, White C, Singh J. A novel approach to the management of a central giant cell granuloma with denosumab: a case report and review of current treatments. J Craniomaxillofac Surg. 2015;43:1127-32.
https://doi.org/10.1016/j.jcms.2015.04.011
PMid:26032758

 

44. Jerkins D, Malotky M, Miremadi R, Dole M. Central giant cell granuloma of the mandible requiring multiple treatment modalities: a case report. J Oral Maxillofac Surg. 2016;74:1596-607.
https://doi.org/10.1016/j.joms.2016.02.019
PMid:27000410

 

45. Joshi S, Koranne V, Pawar S, Pawar P, Lakhani K,Salema H. Conservative management of central giant cell granuloma - A case report. J Indian Acad Oral Med Radiol 2023;35:141-3.
https://doi.org/10.4103/jiaomr.jiaomr_236_22

 

46. Khafif A, Krempl G, Medina JE. Treatment of giant cell granuloma of the maxilla with intralesional injection of steroids. Head Neck. 2000;22:822-5.
https://doi.org/10.1002/1097-0347(200012)22:8<822::AID-HED12>3.0.CO;2-W
PMid:11084644

 

47. Kurtz M, Mesa M, Alberto P. Treatment of a central giant cell lesion of the mandible with intralesional glucocorticosteroids. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:636-7.
https://doi.org/10.1067/moe.2001.115721
PMid:11402273

 

48. Lietman SA, Levine MA. Resolution of giant cell granuloma after treatment with calcitonin. Oral Oncology Extra. 2005;41:125-7.
https://doi.org/10.1016/j.ooe.2005.02.009

 

49. Mariz BALA, Migliorati CA, Alves FA, Penteado FM, Carvalho NP Filho, Santos-Silva AR, et al. Successful denosumab treatment for central giant cell granuloma in a 9-year-old child. Spec Care Dentist. 2021;41:519-25.
https://doi.org/10.1111/scd.12588
PMid:33760257

 

50. Matos FR, Sarmento DJS, Neto AC, Miguel MCC, da Silveira ÉJD. Central giant cell lesion in pediatric patient: case report and literature review of 33 cases. Int J Clin Dent. 2016;6:33-42.

 

51. Mohanty S, Jhamb A. Central giant cell lesion of mandible managed by intralesional triamcinolone injections. A report of two cases and literature review. Med Oral Patol Oral Cir Bucal. 2009;14:E98-102.

 

52. Moura LB, Tarquinio SBC, Gomes APN, Schinestsck AR, Torriani MA. Modified approach to central giant cell lesion. J Clin Pediatr Dent. 2018;42:292-4.
https://doi.org/10.17796/1053-4628-42.4.9
PMid:29750618

 

53. Mukdad M, Barut O, Sjöström M. Intralesional corticosteroid injections as first option for management of giant cell lesion of the lower jaw in a 56-year-old patient: a case report and brief literature review. Oral Maxillofac Surg Cases. 2022;8:100283.
https://doi.org/10.1016/j.omsc.2022.100283

 

54. Naidu A, Malmquist MP, Denham CA, Schow SR. Management of central giant cell granuloma with subcutaneous denosumab therapy. J Oral Maxillofac Surg. 2014;72:2469-84.
https://doi.org/10.1016/j.joms.2014.06.456
PMid:25262402

 

55. Nilesh K, Dadhich A, Patil R. Management of recurrent central giant cell granuloma of mandible using intralesional corticosteroid with long-term follow-up. BMJ Case Rep. 2020;13:e237200.
https://doi.org/10.1136/bcr-2020-237200
PMid:32928838 PMCid:PMC7490931

 

56. Nogueira RL, Teixeira RC, Cavalcante RB, Ribeiro RA, Rabenhosrt SH. Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases. Int J Oral Maxillofac Surg. 2010;39:1204-10.
https://doi.org/10.1016/j.ijom.2010.06.015
PMid:20674272

 

57. O'Connell JE, Bowe C, Murphy C, Toner M, Kearns GJ. Aggressive giant cell lesion of the jaws: a review of management options and report of a mandibular lesion treated with denosumab. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:e191-8.
https://doi.org/10.1016/j.oooo.2015.07.011
PMid:26340897

 

58. O'Connell JE, Kearns GJ. Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases. Ir J Med Sci. 2013;182:163-70.
https://doi.org/10.1007/s11845-012-0858-x
PMid:23099991

 

59. O'Regan EM, Gibb DH, Odell EW. Rapid growth of giant cell granuloma in pregnancy treated with calcitonin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:532-8.
https://doi.org/10.1067/moe.2001.119246
PMid:11709690

 

60. Pogrel MA, Regezi JA, Harris ST, Goldring SR. Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases. J Oral Maxillofac Surg. 1999;57:848-53.
https://doi.org/10.1016/S0278-2391(99)90828-5
PMid:10416634

 

61. Rachmiel A, Emodi O, Sabo E, Aizenbud D, Peled M. Combined treatment of aggressive central giant cell granuloma in the lower jaw. J Craniomaxillofac Surg. 2012;40:292-7.
https://doi.org/10.1016/j.jcms.2011.04.002
PMid:21570312

 

62. Rajeevan NS, Soumithran CS. Intralesional corticosteroid injection for central giant cell granuloma. A case report. Int J Oral Maxillofac Surg. 1998;27:303-4.
https://doi.org/10.1016/S0901-5027(05)80620-4
PMid:9698180

 

63. Romero M, Romance A, Garcia-Recuero JI, Fernández Á. Orthopedic and orthodontic treatment in central giant cell granuloma treated with calcitonin. Cleft Palate Craniofac J. 2011;48:519-25.
https://doi.org/10.1597/10-091
PMid:20815718

 

64. Schreuder WH, Coumou AW, Kessler PA, de Lange J. Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab. J Oral Maxillofac Surg. 2014;72:1301-9.
https://doi.org/10.1016/j.joms.2014.02.017
PMid:24835517

 

65. Schütz P, El-Bassuoni KH, Munish J, Hamed HH, Padwa BL. Aggressive central giant cell granuloma of the mandible. J Oral Maxillofac Surg. 2010;68:2537-44.
https://doi.org/10.1016/j.joms.2009.06.042
PMid:20708322

 

66. Sezer B, Koyuncu B, Gomel M, Günbay T. Intralesional corticosteroid injection for central giant cell granuloma: a case report and review of the literature. Turk J Pediatr. 2005;47:75-81.

 

67. Shirani G, Abbasi AJ, Mohebbi SZ, Shirinbak I. Management of a locally invasive central giant cell granuloma (CGCG) of mandible: report of an extraordinary large case. J Craniomaxillofac Surg. 2011;39:530-3.
https://doi.org/10.1016/j.jcms.2010.10.018
PMid:21159518

 

68. Stagner AM, Sajed DP, Nielsen GP, Ebb DH, Faquin WC, Chebib I, et al. Giant cell lesions of the maxillofacial skeleton express RANKL by RNA in situ hybridization regardless of histologic pattern. Am J Surg Pathol. 2019;43:819-26.
https://doi.org/10.1097/PAS.0000000000001257
PMid:30998511

 

69. Tallent B, Padilla RJ, McKay C, Foreman AKM, Fan Z, Blatt J. Response of central giant cell granuloma of the jaw to imatinib. J Pediatr Hematol Oncol. 2023;45:278-80.
https://doi.org/10.1097/MPH.0000000000002608
PMid:36706268

 

70. Tarsitano A, Del Corso G, Pizzigallo A, Marchetti C. Aggressive central giant cell granuloma of the mandible treated with conservative surgical enucleation and interferon-α-2a: complete remission with long-term follow-up. J Oral Maxillofac Surg. 2015;73:2149-54.
https://doi.org/10.1016/j.joms.2015.04.029
PMid:25985764

 

71. Toferer A, Truschnegg A, Merl L, Liegl-Atzwanger B, Zemann W, Beham A. Dilemma in the treatment of a central giant cell granuloma. J Clin Pediatr Dent. 2021;45:337-40.
https://doi.org/10.17796/1053-4625-45.5.8
PMid:34740263

 

72. Wendt FP, Torriani MA, Gomes AP, de Araujo LM, Torriani DD. Intralesional corticosteroid injection for central giant cell granuloma: an alternative treatment for children. J Dent Child (Chic). 2009;76:229-32.

 

73. Yazici N, Yalçin B, Yilmaz T, Akyüz C, Oguz KK, Arzu Sungur, et al. Surgery and calcitonin therapy in childhood central giant cell granuloma. Int J Pediatr Otorhinolaryngol. 2006;1:297-300.
https://doi.org/10.1016/j.pedex.2006.09.002

 

74. Allon DM, Anavi Y, Calderon S. Central giant cell lesion of the jaw: nonsurgical treatment with calcitonin nasal spray. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:811-8.
https://doi.org/10.1016/j.tripleo.2009.02.013
PMid:19464656

 

75. Borges HO, Machado RA, Vidor MM, Beltrão RG, Heitz C, Filho MS. Calcitonin: a non-invasive giant cells therapy. Int J Pediatr Otorhinolaryngol. 2008;72:959-63.
https://doi.org/10.1016/j.ijporl.2008.03.016
PMid:18466982

 

76. Bredell M, Rordorf T, Kroiss S, Rücker M, Zweifel DF, Rostetter C. Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study. J Oral Maxillofac Surg. 2018;76:775-84.
https://doi.org/10.1016/j.joms.2017.09.013
PMid:29035698

 

77. Carlos R, Sedano HO. Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:161-6.
https://doi.org/10.1067/moe.2002.119971
PMid:11862204

 

78. Chandna P, Srivastava N, Bansal V, Wadhwan V, Dubey P. Peripheral and central giant cell lesions in children: institutional experience at Subharti dental college and hospital. Indian J Med Paediatr Oncol. 2017;38:440-6.
https://doi.org/10.4103/ijmpo.ijmpo_17_16
PMid:29333009 PMCid:PMC5759061

 

79. Choe M, Smith V, Okcu MF, Wulff J, Gruner S, Huisman TAGM, Venkatramani R. Treatment of central giant cell granuloma in children with denosumab. Pediatr Blood Cancer. 2021;68:e28778.
https://doi.org/10.1002/pbc.28778
PMid:33089644

 

80. de Lange J, Rosenberg AJ, van den Akker HP, Koole R, Wirds JJ, van den Berg H. Treatment of central giant cell granuloma of the jaw with calcitonin. Int J Oral Maxillofac Surg. 1999;28:372-6.
https://doi.org/10.1016/S0901-5027(99)80086-1
PMid:10535540

 

81. Dolanmaz D, Esen A, Mihmanlı A, Işık K. Management of central giant cell granuloma of the jaws with intralesional steroid injection and review of the literature. Oral Maxillofac Surg. 2016;20:203-9.
https://doi.org/10.1007/s10006-015-0530-5
PMid:26481917

 

82. Harris M. Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg. 1993;31:89-94.
https://doi.org/10.1016/0266-4356(93)90168-V
PMid:8471587

 

83. Kim TS, Usera GL, Ruggiero SL, Weinerman SA. Improvement of giant cell lesions of the jaw treated with high and low doses of denosumab: a case series. JBMR Plus. 2017;1:101-6.
https://doi.org/10.1002/jbm4.10010
PMid:30283883 PMCid:PMC6124168

 

84. Maia Nogueira RL, Osterne RL, Cavalcante RB, Abreu RT. Surgical treatment, oral rehabilitation, and orthognathic surgery after failure of pharmacologic treatment of central giant cell lesion: a case report. J Oral Maxillofac Surg. 2016;74:2567.e1-2567.e10.
https://doi.org/10.1016/j.joms.2016.08.038
PMid:27677684

 

85. Niedzielska I, Bielecki M, Bąk M, Dziuk B, Niedzielski D. Bony canal method of dexamethasone injections in aggressive form of central giant cell granuloma-case series. Medicina (Kaunas). 2023;59:250.
https://doi.org/10.3390/medicina59020250
PMid:36837452 PMCid:PMC9961085

 

86. Nogueira RLM, Osterne RLV, Lima Verde RMB, Azevedo NO, Teixeira RC, Cavalcante RB. Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study. Br J Oral Maxillofac Surg. 2020;58:e283-9.
https://doi.org/10.1016/j.bjoms.2020.07.032
PMid:32792199

 

87. Pogrel MA. Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg. 2003;61:649-53; discussion 53-4.
https://doi.org/10.1053/joms.2003.50129
PMid:12796868

 

88. Rhou YJJ, Wang CJ, Nguyen M, Vanderniet JA, Munns CF, Coleman H, Kim J, Holmes-Walker DJ, Lim L, Girgis CM. Clinical and radiologic response of central giant cell granuloma to denosumab: a 6-year prospective observational study. Calcif Tissue Int. 2022;110:464-74.
https://doi.org/10.1007/s00223-021-00935-z
PMid:35088118

 

89. Schreuder WH, Peacock ZS, Ebb D, Chuang SK, Kaban LB. Adjuvant antiangiogenic treatment for aggressive giant cell lesions of the jaw: a 20-year experience at Massachusetts general hospital. J Oral Maxillofac Surg. 2017;75:105-18.
https://doi.org/10.1016/j.joms.2016.06.007
PMid:27393579

 

90. Vanderniet JA, Wall CL, Mullins A, London K, Lim L, Hibbert S, et al. Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone. 2022;159:116395.
https://doi.org/10.1016/j.bone.2022.116395
PMid:35331976

 

91. Elias LS, Costa RF, Carvalho MA, Batista AC, Silva TA, Leles CR, et al. Markers of bone remodeling in neoplastic and bone-related lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110:624-31.
https://doi.org/10.1016/j.tripleo.2010.06.014
PMid:20955951

 

92. Osterne RL, Araújo PM, de Souza-Carvalho AC, Cavalcante RB, Sant'Ana E, Nongueira RL. Intralesional corticosteroid injections in the treatment of central giant cell lesions of the jaws: a meta-analytic study. Med Oral Patol Oral Cir Bucal. 2013;18:e226-32.
https://doi.org/10.4317/medoral.18345
PMid:23385503 PMCid:PMC3613330

 

93. Batista Severo ML, Lopes MLDS, Miguel MCDC, Germano AR, Nogueira RLM, Turatti E, et al. Immunoexpression of calcitonin and glucocorticoid receptors in central giant cell lesions of the jaws. J Oral Pathol Med. 2018;47:907-13.
https://doi.org/10.1111/jop.12766
PMid:30028524

 

94. Xie J, Guo J, Kanwal Z, Wu M, Lv X, Ibrahim NA, et al. Calcitonin and bone physiology: in vitro, in vivo, and clinical investigations. Int J Endocrinol. 2020;2020:3236828.
https://doi.org/10.1155/2020/3236828
PMid:32963524 PMCid:PMC7501564

 

95. Tabrizi R, Fardisi S, Zamiri B, Amanpour S, Karagah T. Can calcitonin nasal spray reduce the risk of recurrence of central giant cell granuloma of the jaws? A double-blind clinical trial. Int J Oral Maxillofac Surg. 2016;45:756-9.
https://doi.org/10.1016/j.ijom.2016.02.016
PMid:26993105

 

96. Polyzos SA, Makras P, Tournis S, Anastasilakis AD. Off-label uses of denosumab in metabolic bone diseases. Bone. 2019;129:115048.
https://doi.org/10.1016/j.bone.2019.115048
PMid:31454537